• 1
    Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinaemia of infants. Lancet 1958; 271: 10947.
  • 2
    Bryla DA. Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia. Development, design, and sample composition. Pediatrics 1985; 5: 38792.
  • 3
    Mills JF, Tudehope D. Fibreoptic phototherapy for neonataljaundice. Cochrane Database Syst Rev 2001; (1):CD002060. Art. No.: CD002060. DOI: 10.1002/14651858.CD002060.
  • 4
    Suresh G, Martin CL, Soll R. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. Cochrane Database Syst Rev 2003; (2):CD004207. Art. No.: CD004207. DOI: 10.1002/14651858.CD004207.
  • 5
    Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002; (3):003313. Art. No.: CD003313. DOI: 10.1002/14651858.CD003313.
  • 6
    Thayyil S, Milligan D. Single versus double volume exchange transfusion in jaundiced newborn infants. Cochrane Database Syst Rev 2006; Oct 18;(4):CD004592. Art. No.: CD004592. DOI: 10.1002/14651858.CD004592.pub2.
  • 7
    Thomas JT, Muller P, Wilkinson C. Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization. Cochrane Database Syst Rev 2007; Apr 18;(2):CD005541. Art. No.: CD005541. DOI: 10.1002/14651858.CD005541.pub2.
  • 8
    Mills JF, Argus B. Early intravenous nutrition for the prevention of neonatal jaundice. Cochrane Database Syst Rev 2003; (3): CD003846. Art. No.: CD003846. DOI: 10.1002/14651858.CD003846.
  • 9
    Evans D. Neonatal jaundice. Clin Evid (Online) 2007; 06:319 pii: 0319.
  • 10
    Hulzebos CV, van Imhoff DE, Bos AF, Ahlfors CE, Verkade HJ, Dijk PH. Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants. Arch Dis Child Fetal Neonatal Ed 2008; 93: F3848.
  • 11
    Trikalinos TA, Chung M, Lau J, Ip S. Systematic review of screening for bilirubin encephalopathy in neonates. Pediatrics 2009; 124: 116271.
  • 12
    Ip S, Chung M, Trikalinos T, DeVine D, Lau J. Screening for bilirubin encephalopathy. Evidence synthesis no. 72. AHRQ Publication No.10-05140-EF-1. Rockville, MD: Agency for Healthcare Research and Quality, 2009.
  • 13
    De Luca D, Jakcson GL, Tridente A, Carnielli VP, Engle WD. Transcutaneous bilirubin nomograms. A systematic review of population differences and analysis of bilirubin kinetics. Arch Pediatr Adolesc Med 2009; 163: 10549.
  • 14
    Chavla D, Parmar V. Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: a systematic review and meta- analysis. Indian Pediatr 2010; 47: 4017.
  • 15
    Long J, Zhang S, Fang X, Luo Y, Liu J. Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence. Acta Paediatr 2011; 100: 96671. doi: 10.1111/j.1651-2227.2011.02176.x.
  • 16
    Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, et al. American academy of pediatrics subcommittee on hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e13053.
  • 17
    American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297316.
  • 18
    Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance. BMJ 2010; 340: 11906.
  • 19
    Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infants ≥ 35 weeks’ gestation: an update with clarifications. Pediatrics 2009; 124: 11938.
  • 20
    Morris BH, Oh W, Tyson JE, Stevenson DK, et al., for the NICHD Neonatal Research Network Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008; 359: 188596.
  • 21
    Mishra S, Chawla D, Agarwal R, Deorari AK, Paul VK, Bhutani VK. Transcutaneous bilirubinometry reduces the need for blood sampling in neonates with visible jaundice. Acta Paediatr 2009; 98: 19169.
  • 22
    De Luca D, Zecca E, Corsello M, Tiberi E, Semeraro C, Romagnoli C. Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck. Arch Dis Child Fetal Neonatal Ed 2008; 93: F1359.
  • 23
    Kumar P, Murki S, Malik GK, Chawla D, Deorari AK, Karthi N, et al. Light emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: a multi center randomized controlled trial. Indian Pediatr 2010; 47: 1317.
  • 24
    Tayman C, Tatli MM, Aydemir S, Karadag A. Overhead is superior to underneath light-emitting diode phototherapy in the treatment of neonatal jaundice: a comparative study. J Paediatr Child Health 2010; 46: 2347.
  • 25
    Donneborg ML, Knudsen KB, Ebbesen F. Effect of infants’ position on serum bilirubin level during conventional phototherapy. Acta Paediatr 2010; 99: 11314.
  • 26
    Sivanandan S, Chawla D, Misra S, Agarwal R, Deorari AK. Effect of sling application on efficacy of phototherapy in healthy term neonates with nonhemolytic jaundice: a randomized conrolled trial. Indian Pediatr 2009; 46: 238.
  • 27
    Silva I, Luco M, Tapia JL, Pérez ME, Salinas JA, Flores J, et al. Single vs. double phototherapy in the treatment of full-term newborns with nonhemolytic hyperbilirubinemia. J Pediatr (Rio J) 2009; 85: 4558.
  • 28
    Naderi S, Safdarian F, Mazloomi D, Bushehri E, Hamidian R. Efficacy of double and triple phototherapy in term newborns with hyperbilirubinemia: the first clinical trial. Pediatr Neonatol 2009; 50: 2669.
  • 29
    Saeidi R, Heydarian F, Fakehi V. Role of intravenous extra fluid therapy in icteric neonates receiving phototherapy. Saudi Med J 2009; 30: 11769.
  • 30
    Boonyarittipong P, Kriangburapa W, Booranavanich K. Effectiveness of double- surface intensive phototherapy versus single-surface intensive phototherapy for neonatal hyperbilirubinemia. J Med Assoc Thai 2008; 91: 505.
  • 31
    Bisceglia M, Indrio F, Riezzo G, Poerio V, Corapi U, Raimondi F. The effect of prebiotics in the management of neonatal hyperbilirubinaemia. Acta Paediatr 2009; 98: 157981.
  • 32
    Jaikrishan, Kumar P, Narang A. Gemfibrozil in late preterm and term neonates with moderate jaundice: a randomized controlled trial. Indian Pediatr 2009; 46: 10639.
  • 33
    Sakha SH, Gharehbaghi MM, Rahbani ME. The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. Indian J Med Sci 2009; 63: 1749.
  • 34
    Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA. Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). Southeast Asian J Trop Med Public Health 2008; 39: 55761.
  • 35
    Shahian M, Moslehi MA. Effect of albumin administration prior to exchange transfusion in term neonates with hyperbilirubinemia--a randomized controlled trial. Indian Pediatr 2010; 47: 2414.
  • 36
    Chen SP, Tian LL, Liu FL. Clinical observation of Yinzhihuang oral liquid on prevention of the premature infantile jaundice. Chin J Integr Med 2009; 15: 299302.
  • 37
    Qiu XL, Yang QL, Sun XY. Colonic dripping with Taihuang liquid for treatment of neonatal hyperbilirubinemia. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28: 9313.
  • 38
    Stokowski LA. Fundamentals of phototherapy for neonatal jaundice. Adv Neonatal Care 2006; 6: 30312.
  • 39
    Bhutani VK, Johnson L. Kernicterus in the 21st century: frequently asked question. J Perinatol 2009; 29: S204.
  • 40
    Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus registry. J Perinatol 2009; 29: S2545.
  • 41
    US Preventive Services Task Force. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: US preventive services task force recommendation statement. Pediatrics 2009; 124: 11727.
  • 42
    Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics 2006; 117: e85562.
  • 43
    Kuzniewicz MW, Escobar GJ, Newman TB. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics 2009; 124: 10319.
  • 44
    Mah MP, Clark SL, Akhigbe E, Englebright J, Frye DK, et al. Reduction of severe hyperbilirubinemia after institution of predischarge bilirubin screening. Pediatrics 2010; 125: e11438.
  • 45
    Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008; 358: 9208.
  • 46
    Newman TB, Kuzniewicz MW, Liljestrand P, Wi S, McCulloch C, Escobar GJ. Numbers needed to treat with phototherapy according to American academy of pediatrics guidelines. Pediatrics 2009; 123: 13529.
  • 47
    Olusanya BO, Akande AA, Emokpae A, Olowe SA. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Trop Med Int Health 2009; 14: 30110.
  • 48
    Mollison PL, Walker W. Controlled trials of the treatment of haemolytic disease of the newborn. Lancet 1952; 1: 42933.
  • 49
    Cuperus FJ, Hafkamp AM, Hulzebos CV, Verkade HJ. Pharmacological therapies for unconjugated hyperbilirubinemia. Curr Pharm Des 2009; 15: 292738.
  • 50
    Huang W, Zhang J, Moore DD. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest 2004; 113: 13743.
  • 51
    Dijk PH, de Vries TW, de Beer JJ, Dutch Pediatric Association. Guideline ‘Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks’. Ned Tijdschr Geneeskd 2009; 153: A93.